nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—SLC22A2—Vinblastine—head and neck cancer	0.267	0.475	CbGbCtD
Levofloxacin—CYP1A2—Fluorouracil—head and neck cancer	0.0877	0.156	CbGbCtD
Levofloxacin—ABCB1—Vinblastine—head and neck cancer	0.0711	0.126	CbGbCtD
Levofloxacin—ABCB1—Docetaxel—head and neck cancer	0.0586	0.104	CbGbCtD
Levofloxacin—CYP3A4—Vinblastine—head and neck cancer	0.0426	0.0758	CbGbCtD
Levofloxacin—CYP3A4—Docetaxel—head and neck cancer	0.0351	0.0624	CbGbCtD
Levofloxacin—SLC22A4—glottis—head and neck cancer	0.0151	0.562	CbGeAlD
Levofloxacin—SLC22A4—larynx—head and neck cancer	0.00536	0.199	CbGeAlD
Levofloxacin—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.00367	0.317	CbGdCrCtD
Levofloxacin—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.0036	0.311	CbGdCrCtD
Levofloxacin—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.00231	0.2	CbGdCrCtD
Levofloxacin—TOP2A—Vincristine—Vinblastine—head and neck cancer	0.00198	0.171	CbGdCrCtD
Levofloxacin—SLC22A4—neck—head and neck cancer	0.00142	0.0527	CbGeAlD
Levofloxacin—TOP2A—G0 and Early G1—CCNA1—head and neck cancer	0.00138	0.0782	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 1—CCNA1—head and neck cancer	0.00122	0.0694	CbGpPWpGaD
Levofloxacin—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.0011	0.0622	CbGpPWpGaD
Levofloxacin—Skin exfoliation—Docetaxel—head and neck cancer	0.001	0.00263	CcSEcCtD
Levofloxacin—Ataxia—Fluorouracil—head and neck cancer	0.000994	0.0026	CcSEcCtD
Levofloxacin—Neuropathy—Docetaxel—head and neck cancer	0.000986	0.00258	CcSEcCtD
Levofloxacin—Alopecia—Vinblastine—head and neck cancer	0.000984	0.00258	CcSEcCtD
Levofloxacin—Dry skin—Fluorouracil—head and neck cancer	0.000969	0.00254	CcSEcCtD
Levofloxacin—Oesophagitis—Docetaxel—head and neck cancer	0.00096	0.00252	CcSEcCtD
Levofloxacin—Neoplasm—Docetaxel—head and neck cancer	0.00095	0.00249	CcSEcCtD
Levofloxacin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000945	0.00248	CcSEcCtD
Levofloxacin—Lightheadedness—Docetaxel—head and neck cancer	0.00094	0.00246	CcSEcCtD
Levofloxacin—Pulmonary oedema—Docetaxel—head and neck cancer	0.000935	0.00245	CcSEcCtD
Levofloxacin—Angiopathy—Hydroxyurea—head and neck cancer	0.000921	0.00241	CcSEcCtD
Levofloxacin—Dysphagia—Fluorouracil—head and neck cancer	0.000913	0.00239	CcSEcCtD
Levofloxacin—Sepsis—Docetaxel—head and neck cancer	0.000912	0.00239	CcSEcCtD
Levofloxacin—Chills—Hydroxyurea—head and neck cancer	0.000911	0.00239	CcSEcCtD
Levofloxacin—Eosinophilia—Fluorouracil—head and neck cancer	0.000904	0.00237	CcSEcCtD
Levofloxacin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000899	0.00236	CcSEcCtD
Levofloxacin—Alopecia—Hydroxyurea—head and neck cancer	0.000897	0.00235	CcSEcCtD
Levofloxacin—Anaemia—Vinblastine—head and neck cancer	0.000896	0.00235	CcSEcCtD
Levofloxacin—Angina pectoris—Fluorouracil—head and neck cancer	0.00089	0.00233	CcSEcCtD
Levofloxacin—Phlebitis—Docetaxel—head and neck cancer	0.000885	0.00232	CcSEcCtD
Levofloxacin—Erythema—Hydroxyurea—head and neck cancer	0.000884	0.00232	CcSEcCtD
Levofloxacin—Thrombophlebitis—Docetaxel—head and neck cancer	0.000881	0.00231	CcSEcCtD
Levofloxacin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000877	0.0023	CcSEcCtD
Levofloxacin—Malaise—Vinblastine—head and neck cancer	0.000874	0.00229	CcSEcCtD
Levofloxacin—Vertigo—Vinblastine—head and neck cancer	0.000871	0.00228	CcSEcCtD
Levofloxacin—Leukopenia—Vinblastine—head and neck cancer	0.000868	0.00227	CcSEcCtD
Levofloxacin—Pancytopenia—Fluorouracil—head and neck cancer	0.000867	0.00227	CcSEcCtD
Levofloxacin—Swelling—Docetaxel—head and neck cancer	0.000865	0.00226	CcSEcCtD
Levofloxacin—SLC22A4—trachea—head and neck cancer	0.000855	0.0317	CbGeAlD
Levofloxacin—Deafness—Docetaxel—head and neck cancer	0.000853	0.00223	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000849	0.00222	CcSEcCtD
Levofloxacin—Hepatic failure—Docetaxel—head and neck cancer	0.000849	0.00222	CcSEcCtD
Levofloxacin—TOP2A—thyroid gland—head and neck cancer	0.000845	0.0314	CbGeAlD
Levofloxacin—Hypertension—Vinblastine—head and neck cancer	0.000837	0.00219	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000834	0.00218	CcSEcCtD
Levofloxacin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00082	0.00215	CcSEcCtD
Levofloxacin—Pneumonia—Fluorouracil—head and neck cancer	0.000819	0.00215	CcSEcCtD
Levofloxacin—Anaemia—Hydroxyurea—head and neck cancer	0.000817	0.00214	CcSEcCtD
Levofloxacin—Discomfort—Vinblastine—head and neck cancer	0.000815	0.00214	CcSEcCtD
Levofloxacin—Hot flush—Docetaxel—head and neck cancer	0.000815	0.00214	CcSEcCtD
Levofloxacin—Infestation NOS—Fluorouracil—head and neck cancer	0.000814	0.00213	CcSEcCtD
Levofloxacin—Infestation—Fluorouracil—head and neck cancer	0.000814	0.00213	CcSEcCtD
Levofloxacin—Menopausal symptoms—Docetaxel—head and neck cancer	0.000808	0.00212	CcSEcCtD
Levofloxacin—Atrial fibrillation—Docetaxel—head and neck cancer	0.000805	0.00211	CcSEcCtD
Levofloxacin—Visual disturbance—Docetaxel—head and neck cancer	0.000805	0.00211	CcSEcCtD
Levofloxacin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000803	0.0021	CcSEcCtD
Levofloxacin—Renal impairment—Docetaxel—head and neck cancer	0.000801	0.0021	CcSEcCtD
Levofloxacin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000798	0.00209	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000798	0.00209	CcSEcCtD
Levofloxacin—Dermatitis bullous—Docetaxel—head and neck cancer	0.000798	0.00209	CcSEcCtD
Levofloxacin—Malaise—Hydroxyurea—head and neck cancer	0.000797	0.00209	CcSEcCtD
Levofloxacin—Stomatitis—Fluorouracil—head and neck cancer	0.000794	0.00208	CcSEcCtD
Levofloxacin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000792	0.00207	CcSEcCtD
Levofloxacin—Leukopenia—Hydroxyurea—head and neck cancer	0.000791	0.00207	CcSEcCtD
Levofloxacin—Cardiac failure—Docetaxel—head and neck cancer	0.000781	0.00205	CcSEcCtD
Levofloxacin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000775	0.00203	CcSEcCtD
Levofloxacin—Epistaxis—Fluorouracil—head and neck cancer	0.000768	0.00201	CcSEcCtD
Levofloxacin—Hyponatraemia—Docetaxel—head and neck cancer	0.000766	0.00201	CcSEcCtD
Levofloxacin—Sinusitis—Fluorouracil—head and neck cancer	0.000764	0.002	CcSEcCtD
Levofloxacin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000763	0.002	CcSEcCtD
Levofloxacin—Pain in extremity—Docetaxel—head and neck cancer	0.000763	0.002	CcSEcCtD
Levofloxacin—Agranulocytosis—Fluorouracil—head and neck cancer	0.00076	0.00199	CcSEcCtD
Levofloxacin—Anorexia—Vinblastine—head and neck cancer	0.000754	0.00198	CcSEcCtD
Levofloxacin—Migraine—Docetaxel—head and neck cancer	0.000751	0.00197	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000747	0.00196	CcSEcCtD
Levofloxacin—Discomfort—Hydroxyurea—head and neck cancer	0.000744	0.00195	CcSEcCtD
Levofloxacin—Haemoglobin—Fluorouracil—head and neck cancer	0.000735	0.00192	CcSEcCtD
Levofloxacin—Rhinitis—Fluorouracil—head and neck cancer	0.000733	0.00192	CcSEcCtD
Levofloxacin—Haemorrhage—Fluorouracil—head and neck cancer	0.000731	0.00192	CcSEcCtD
Levofloxacin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000727	0.00191	CcSEcCtD
Levofloxacin—Pharyngitis—Fluorouracil—head and neck cancer	0.000726	0.0019	CcSEcCtD
Levofloxacin—Oedema—Hydroxyurea—head and neck cancer	0.000722	0.00189	CcSEcCtD
Levofloxacin—Ataxia—Docetaxel—head and neck cancer	0.000717	0.00188	CcSEcCtD
Levofloxacin—Infection—Hydroxyurea—head and neck cancer	0.000717	0.00188	CcSEcCtD
Levofloxacin—Paraesthesia—Vinblastine—head and neck cancer	0.00071	0.00186	CcSEcCtD
Levofloxacin—Dehydration—Docetaxel—head and neck cancer	0.000709	0.00186	CcSEcCtD
Levofloxacin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000708	0.00185	CcSEcCtD
Levofloxacin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000706	0.00185	CcSEcCtD
Levofloxacin—Skin disorder—Hydroxyurea—head and neck cancer	0.000701	0.00184	CcSEcCtD
Levofloxacin—Dry skin—Docetaxel—head and neck cancer	0.000699	0.00183	CcSEcCtD
Levofloxacin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000697	0.00182	CcSEcCtD
Levofloxacin—Breast disorder—Docetaxel—head and neck cancer	0.000689	0.00181	CcSEcCtD
Levofloxacin—Anorexia—Hydroxyurea—head and neck cancer	0.000688	0.0018	CcSEcCtD
Levofloxacin—Decreased appetite—Vinblastine—head and neck cancer	0.000688	0.0018	CcSEcCtD
Levofloxacin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000687	0.0018	CcSEcCtD
Levofloxacin—Cramp muscle—Docetaxel—head and neck cancer	0.000687	0.0018	CcSEcCtD
Levofloxacin—Nasopharyngitis—Docetaxel—head and neck cancer	0.000682	0.00179	CcSEcCtD
Levofloxacin—Constipation—Vinblastine—head and neck cancer	0.000677	0.00177	CcSEcCtD
Levofloxacin—Pain—Vinblastine—head and neck cancer	0.000677	0.00177	CcSEcCtD
Levofloxacin—SLC22A4—thyroid gland—head and neck cancer	0.000676	0.0251	CbGeAlD
Levofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—head and neck cancer	0.000669	0.0379	CbGpPWpGaD
Levofloxacin—Dysphagia—Docetaxel—head and neck cancer	0.000659	0.00173	CcSEcCtD
Levofloxacin—Arrhythmia—Fluorouracil—head and neck cancer	0.000653	0.00171	CcSEcCtD
Levofloxacin—Feeling abnormal—Vinblastine—head and neck cancer	0.000652	0.00171	CcSEcCtD
Levofloxacin—Bronchospasm—Docetaxel—head and neck cancer	0.000648	0.0017	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000647	0.00169	CcSEcCtD
Levofloxacin—Alopecia—Fluorouracil—head and neck cancer	0.000646	0.00169	CcSEcCtD
Levofloxacin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000643	0.00169	CcSEcCtD
Levofloxacin—Angina pectoris—Docetaxel—head and neck cancer	0.000642	0.00168	CcSEcCtD
Levofloxacin—Somnolence—Hydroxyurea—head and neck cancer	0.000641	0.00168	CcSEcCtD
Levofloxacin—Erythema—Fluorouracil—head and neck cancer	0.000636	0.00167	CcSEcCtD
Levofloxacin—Dyspepsia—Hydroxyurea—head and neck cancer	0.000635	0.00166	CcSEcCtD
Levofloxacin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000627	0.00164	CcSEcCtD
Levofloxacin—Pancytopenia—Docetaxel—head and neck cancer	0.000626	0.00164	CcSEcCtD
Levofloxacin—Abdominal pain—Vinblastine—head and neck cancer	0.000625	0.00164	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000623	0.00163	CcSEcCtD
Levofloxacin—Fatigue—Hydroxyurea—head and neck cancer	0.000622	0.00163	CcSEcCtD
Levofloxacin—Constipation—Hydroxyurea—head and neck cancer	0.000617	0.00162	CcSEcCtD
Levofloxacin—Pain—Hydroxyurea—head and neck cancer	0.000617	0.00162	CcSEcCtD
Levofloxacin—Neutropenia—Docetaxel—head and neck cancer	0.000616	0.00161	CcSEcCtD
Levofloxacin—Vision blurred—Fluorouracil—head and neck cancer	0.0006	0.00157	CcSEcCtD
Levofloxacin—Weight decreased—Docetaxel—head and neck cancer	0.000596	0.00156	CcSEcCtD
Levofloxacin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000595	0.00156	CcSEcCtD
Levofloxacin—Pneumonia—Docetaxel—head and neck cancer	0.000591	0.00155	CcSEcCtD
Levofloxacin—Anaemia—Fluorouracil—head and neck cancer	0.000588	0.00154	CcSEcCtD
Levofloxacin—Infestation NOS—Docetaxel—head and neck cancer	0.000588	0.00154	CcSEcCtD
Levofloxacin—Infestation—Docetaxel—head and neck cancer	0.000588	0.00154	CcSEcCtD
Levofloxacin—Hypersensitivity—Vinblastine—head and neck cancer	0.000583	0.00153	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000583	0.00153	CcSEcCtD
Levofloxacin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000579	0.00152	CcSEcCtD
Levofloxacin—Renal failure—Docetaxel—head and neck cancer	0.000578	0.00151	CcSEcCtD
Levofloxacin—Myocardial infarction—Docetaxel—head and neck cancer	0.000576	0.00151	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000576	0.00151	CcSEcCtD
Levofloxacin—Stomatitis—Docetaxel—head and neck cancer	0.000573	0.0015	CcSEcCtD
Levofloxacin—Jaundice—Docetaxel—head and neck cancer	0.000573	0.0015	CcSEcCtD
Levofloxacin—Conjunctivitis—Docetaxel—head and neck cancer	0.000571	0.0015	CcSEcCtD
Levofloxacin—Body temperature increased—Hydroxyurea—head and neck cancer	0.00057	0.00149	CcSEcCtD
Levofloxacin—Leukopenia—Fluorouracil—head and neck cancer	0.00057	0.00149	CcSEcCtD
Levofloxacin—Asthenia—Vinblastine—head and neck cancer	0.000568	0.00149	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000556	0.00146	CcSEcCtD
Levofloxacin—Epistaxis—Docetaxel—head and neck cancer	0.000554	0.00145	CcSEcCtD
Levofloxacin—Agranulocytosis—Docetaxel—head and neck cancer	0.000548	0.00144	CcSEcCtD
Levofloxacin—Myalgia—Fluorouracil—head and neck cancer	0.000542	0.00142	CcSEcCtD
Levofloxacin—Chest pain—Fluorouracil—head and neck cancer	0.000542	0.00142	CcSEcCtD
Levofloxacin—Diarrhoea—Vinblastine—head and neck cancer	0.000541	0.00142	CcSEcCtD
Levofloxacin—Discomfort—Fluorouracil—head and neck cancer	0.000535	0.0014	CcSEcCtD
Levofloxacin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000532	0.00139	CcSEcCtD
Levofloxacin—Haemoglobin—Docetaxel—head and neck cancer	0.00053	0.00139	CcSEcCtD
Levofloxacin—Rhinitis—Docetaxel—head and neck cancer	0.000529	0.00139	CcSEcCtD
Levofloxacin—Haemorrhage—Docetaxel—head and neck cancer	0.000528	0.00138	CcSEcCtD
Levofloxacin—Hepatitis—Docetaxel—head and neck cancer	0.000528	0.00138	CcSEcCtD
Levofloxacin—Hypoaesthesia—Docetaxel—head and neck cancer	0.000525	0.00138	CcSEcCtD
Levofloxacin—TOP2A—lymph node—head and neck cancer	0.000525	0.0195	CbGeAlD
Levofloxacin—Confusional state—Fluorouracil—head and neck cancer	0.000524	0.00137	CcSEcCtD
Levofloxacin—Pharyngitis—Docetaxel—head and neck cancer	0.000524	0.00137	CcSEcCtD
Levofloxacin—Dizziness—Vinblastine—head and neck cancer	0.000523	0.00137	CcSEcCtD
Levofloxacin—Urinary tract disorder—Docetaxel—head and neck cancer	0.000521	0.00137	CcSEcCtD
Levofloxacin—Oedema peripheral—Docetaxel—head and neck cancer	0.00052	0.00136	CcSEcCtD
Levofloxacin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000519	0.00136	CcSEcCtD
Levofloxacin—Oedema—Fluorouracil—head and neck cancer	0.000519	0.00136	CcSEcCtD
Levofloxacin—Connective tissue disorder—Docetaxel—head and neck cancer	0.000518	0.00136	CcSEcCtD
Levofloxacin—Asthenia—Hydroxyurea—head and neck cancer	0.000518	0.00136	CcSEcCtD
Levofloxacin—Urethral disorder—Docetaxel—head and neck cancer	0.000517	0.00136	CcSEcCtD
Levofloxacin—Infection—Fluorouracil—head and neck cancer	0.000516	0.00135	CcSEcCtD
Levofloxacin—Nervous system disorder—Fluorouracil—head and neck cancer	0.000509	0.00133	CcSEcCtD
Levofloxacin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000508	0.00133	CcSEcCtD
Levofloxacin—Visual impairment—Docetaxel—head and neck cancer	0.000508	0.00133	CcSEcCtD
Levofloxacin—Tachycardia—Fluorouracil—head and neck cancer	0.000507	0.00133	CcSEcCtD
Levofloxacin—Vomiting—Vinblastine—head and neck cancer	0.000503	0.00132	CcSEcCtD
Levofloxacin—Erythema multiforme—Docetaxel—head and neck cancer	0.000499	0.00131	CcSEcCtD
Levofloxacin—Headache—Vinblastine—head and neck cancer	0.000496	0.0013	CcSEcCtD
Levofloxacin—Anorexia—Fluorouracil—head and neck cancer	0.000495	0.0013	CcSEcCtD
Levofloxacin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000494	0.00129	CcSEcCtD
Levofloxacin—Eye disorder—Docetaxel—head and neck cancer	0.000493	0.00129	CcSEcCtD
Levofloxacin—Cardiac disorder—Docetaxel—head and neck cancer	0.00049	0.00128	CcSEcCtD
Levofloxacin—Flushing—Docetaxel—head and neck cancer	0.00049	0.00128	CcSEcCtD
Levofloxacin—Hypotension—Fluorouracil—head and neck cancer	0.000485	0.00127	CcSEcCtD
Levofloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000479	0.0271	CbGpPWpGaD
Levofloxacin—Angiopathy—Docetaxel—head and neck cancer	0.000479	0.00125	CcSEcCtD
Levofloxacin—Dizziness—Hydroxyurea—head and neck cancer	0.000477	0.00125	CcSEcCtD
Levofloxacin—Immune system disorder—Docetaxel—head and neck cancer	0.000477	0.00125	CcSEcCtD
Levofloxacin—Mediastinal disorder—Docetaxel—head and neck cancer	0.000476	0.00125	CcSEcCtD
Levofloxacin—Chills—Docetaxel—head and neck cancer	0.000473	0.00124	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000473	0.00124	CcSEcCtD
Levofloxacin—Arrhythmia—Docetaxel—head and neck cancer	0.000471	0.00123	CcSEcCtD
Levofloxacin—Nausea—Vinblastine—head and neck cancer	0.00047	0.00123	CcSEcCtD
Levofloxacin—Insomnia—Fluorouracil—head and neck cancer	0.00047	0.00123	CcSEcCtD
Levofloxacin—Paraesthesia—Fluorouracil—head and neck cancer	0.000466	0.00122	CcSEcCtD
Levofloxacin—Alopecia—Docetaxel—head and neck cancer	0.000466	0.00122	CcSEcCtD
Levofloxacin—Dyspnoea—Fluorouracil—head and neck cancer	0.000463	0.00121	CcSEcCtD
Levofloxacin—Mental disorder—Docetaxel—head and neck cancer	0.000462	0.00121	CcSEcCtD
Levofloxacin—Somnolence—Fluorouracil—head and neck cancer	0.000462	0.00121	CcSEcCtD
Levofloxacin—Erythema—Docetaxel—head and neck cancer	0.000459	0.0012	CcSEcCtD
Levofloxacin—Malnutrition—Docetaxel—head and neck cancer	0.000459	0.0012	CcSEcCtD
Levofloxacin—Vomiting—Hydroxyurea—head and neck cancer	0.000459	0.0012	CcSEcCtD
Levofloxacin—Dyspepsia—Fluorouracil—head and neck cancer	0.000457	0.0012	CcSEcCtD
Levofloxacin—Rash—Hydroxyurea—head and neck cancer	0.000455	0.00119	CcSEcCtD
Levofloxacin—Dermatitis—Hydroxyurea—head and neck cancer	0.000455	0.00119	CcSEcCtD
Levofloxacin—Headache—Hydroxyurea—head and neck cancer	0.000452	0.00118	CcSEcCtD
Levofloxacin—Decreased appetite—Fluorouracil—head and neck cancer	0.000451	0.00118	CcSEcCtD
Levofloxacin—Dysgeusia—Docetaxel—head and neck cancer	0.00045	0.00118	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000448	0.00117	CcSEcCtD
Levofloxacin—Back pain—Docetaxel—head and neck cancer	0.000444	0.00116	CcSEcCtD
Levofloxacin—Pain—Fluorouracil—head and neck cancer	0.000444	0.00116	CcSEcCtD
Levofloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—head and neck cancer	0.000444	0.0251	CbGpPWpGaD
Levofloxacin—Muscle spasms—Docetaxel—head and neck cancer	0.000442	0.00116	CcSEcCtD
Levofloxacin—Nausea—Hydroxyurea—head and neck cancer	0.000429	0.00112	CcSEcCtD
Levofloxacin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000428	0.00112	CcSEcCtD
Levofloxacin—Anaemia—Docetaxel—head and neck cancer	0.000425	0.00111	CcSEcCtD
Levofloxacin—SLC22A4—lymph node—head and neck cancer	0.00042	0.0156	CbGeAlD
Levofloxacin—Urticaria—Fluorouracil—head and neck cancer	0.000413	0.00108	CcSEcCtD
Levofloxacin—Syncope—Docetaxel—head and neck cancer	0.000412	0.00108	CcSEcCtD
Levofloxacin—Leukopenia—Docetaxel—head and neck cancer	0.000411	0.00108	CcSEcCtD
Levofloxacin—Body temperature increased—Fluorouracil—head and neck cancer	0.000411	0.00108	CcSEcCtD
Levofloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000408	0.0231	CbGpPWpGaD
Levofloxacin—Palpitations—Docetaxel—head and neck cancer	0.000406	0.00106	CcSEcCtD
Levofloxacin—CYP1A2—thyroid gland—head and neck cancer	0.000405	0.015	CbGeAlD
Levofloxacin—Loss of consciousness—Docetaxel—head and neck cancer	0.000404	0.00106	CcSEcCtD
Levofloxacin—Cough—Docetaxel—head and neck cancer	0.000401	0.00105	CcSEcCtD
Levofloxacin—Hypertension—Docetaxel—head and neck cancer	0.000397	0.00104	CcSEcCtD
Levofloxacin—Arthralgia—Docetaxel—head and neck cancer	0.000391	0.00102	CcSEcCtD
Levofloxacin—Myalgia—Docetaxel—head and neck cancer	0.000391	0.00102	CcSEcCtD
Levofloxacin—Chest pain—Docetaxel—head and neck cancer	0.000391	0.00102	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000388	0.00102	CcSEcCtD
Levofloxacin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000383	0.001	CcSEcCtD
Levofloxacin—Dry mouth—Docetaxel—head and neck cancer	0.000382	0.001	CcSEcCtD
Levofloxacin—Confusional state—Docetaxel—head and neck cancer	0.000378	0.00099	CcSEcCtD
Levofloxacin—Oedema—Docetaxel—head and neck cancer	0.000375	0.000982	CcSEcCtD
Levofloxacin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000375	0.000982	CcSEcCtD
Levofloxacin—Infection—Docetaxel—head and neck cancer	0.000372	0.000976	CcSEcCtD
Levofloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000371	0.021	CbGpPWpGaD
Levofloxacin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000369	0.0209	CbGpPWpGaD
Levofloxacin—Shock—Docetaxel—head and neck cancer	0.000369	0.000966	CcSEcCtD
Levofloxacin—Nervous system disorder—Docetaxel—head and neck cancer	0.000368	0.000963	CcSEcCtD
Levofloxacin—Pruritus—Fluorouracil—head and neck cancer	0.000367	0.000963	CcSEcCtD
Levofloxacin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000367	0.000962	CcSEcCtD
Levofloxacin—Tachycardia—Docetaxel—head and neck cancer	0.000366	0.000958	CcSEcCtD
Levofloxacin—Skin disorder—Docetaxel—head and neck cancer	0.000364	0.000954	CcSEcCtD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000358	0.0203	CbGpPWpGaD
Levofloxacin—Anorexia—Docetaxel—head and neck cancer	0.000357	0.000936	CcSEcCtD
Levofloxacin—Diarrhoea—Fluorouracil—head and neck cancer	0.000355	0.000931	CcSEcCtD
Levofloxacin—Hypotension—Docetaxel—head and neck cancer	0.00035	0.000918	CcSEcCtD
Levofloxacin—Dizziness—Fluorouracil—head and neck cancer	0.000343	0.0009	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000342	0.000895	CcSEcCtD
Levofloxacin—Insomnia—Docetaxel—head and neck cancer	0.000339	0.000888	CcSEcCtD
Levofloxacin—Paraesthesia—Docetaxel—head and neck cancer	0.000337	0.000882	CcSEcCtD
Levofloxacin—Dyspnoea—Docetaxel—head and neck cancer	0.000334	0.000876	CcSEcCtD
Levofloxacin—Somnolence—Docetaxel—head and neck cancer	0.000333	0.000873	CcSEcCtD
Levofloxacin—Vomiting—Fluorouracil—head and neck cancer	0.00033	0.000865	CcSEcCtD
Levofloxacin—Dyspepsia—Docetaxel—head and neck cancer	0.00033	0.000864	CcSEcCtD
Levofloxacin—Rash—Fluorouracil—head and neck cancer	0.000327	0.000858	CcSEcCtD
Levofloxacin—Dermatitis—Fluorouracil—head and neck cancer	0.000327	0.000857	CcSEcCtD
Levofloxacin—Decreased appetite—Docetaxel—head and neck cancer	0.000326	0.000854	CcSEcCtD
Levofloxacin—Headache—Fluorouracil—head and neck cancer	0.000325	0.000852	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000324	0.000848	CcSEcCtD
Levofloxacin—Fatigue—Docetaxel—head and neck cancer	0.000323	0.000847	CcSEcCtD
Levofloxacin—Pain—Docetaxel—head and neck cancer	0.000321	0.00084	CcSEcCtD
Levofloxacin—Constipation—Docetaxel—head and neck cancer	0.000321	0.00084	CcSEcCtD
Levofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000314	0.0178	CbGpPWpGaD
Levofloxacin—Feeling abnormal—Docetaxel—head and neck cancer	0.000309	0.000809	CcSEcCtD
Levofloxacin—Nausea—Fluorouracil—head and neck cancer	0.000308	0.000808	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000307	0.000803	CcSEcCtD
Levofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—head and neck cancer	0.000301	0.0171	CbGpPWpGaD
Levofloxacin—ABCB1—epithelium—head and neck cancer	0.000297	0.011	CbGeAlD
Levofloxacin—Body temperature increased—Docetaxel—head and neck cancer	0.000296	0.000776	CcSEcCtD
Levofloxacin—Abdominal pain—Docetaxel—head and neck cancer	0.000296	0.000776	CcSEcCtD
Levofloxacin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000286	0.0162	CbGpPWpGaD
Levofloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000277	0.0157	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Docetaxel—head and neck cancer	0.000276	0.000724	CcSEcCtD
Levofloxacin—Asthenia—Docetaxel—head and neck cancer	0.000269	0.000705	CcSEcCtD
Levofloxacin—Pruritus—Docetaxel—head and neck cancer	0.000265	0.000695	CcSEcCtD
Levofloxacin—ABCB1—trachea—head and neck cancer	0.000263	0.00974	CbGeAlD
Levofloxacin—Diarrhoea—Docetaxel—head and neck cancer	0.000256	0.000672	CcSEcCtD
Levofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00025	0.0142	CbGpPWpGaD
Levofloxacin—Dizziness—Docetaxel—head and neck cancer	0.000248	0.000649	CcSEcCtD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000245	0.0139	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000239	0.0136	CbGpPWpGaD
Levofloxacin—Vomiting—Docetaxel—head and neck cancer	0.000238	0.000624	CcSEcCtD
Levofloxacin—Rash—Docetaxel—head and neck cancer	0.000236	0.000619	CcSEcCtD
Levofloxacin—Dermatitis—Docetaxel—head and neck cancer	0.000236	0.000619	CcSEcCtD
Levofloxacin—Headache—Docetaxel—head and neck cancer	0.000235	0.000615	CcSEcCtD
Levofloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000234	0.0133	CbGpPWpGaD
Levofloxacin—ABCB1—lymphoid tissue—head and neck cancer	0.000229	0.00848	CbGeAlD
Levofloxacin—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000225	0.0128	CbGpPWpGaD
Levofloxacin—Nausea—Docetaxel—head and neck cancer	0.000223	0.000583	CcSEcCtD
Levofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—head and neck cancer	0.000221	0.0125	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000218	0.0124	CbGpPWpGaD
Levofloxacin—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000213	0.0121	CbGpPWpGaD
Levofloxacin—ABCB1—thyroid gland—head and neck cancer	0.000208	0.00771	CbGeAlD
Levofloxacin—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000196	0.0111	CbGpPWpGaD
Levofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000193	0.011	CbGpPWpGaD
Levofloxacin—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000188	0.0107	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—TP53—head and neck cancer	0.000186	0.0105	CbGpPWpGaD
Levofloxacin—ABCB1—head—head and neck cancer	0.000184	0.00684	CbGeAlD
Levofloxacin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000181	0.0103	CbGpPWpGaD
Levofloxacin—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000174	0.00984	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.000173	0.00979	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000168	0.0095	CbGpPWpGaD
Levofloxacin—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000165	0.00933	CbGpPWpGaD
Levofloxacin—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000151	0.00857	CbGpPWpGaD
Levofloxacin—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000146	0.00825	CbGpPWpGaD
Levofloxacin—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000145	0.00825	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000131	0.00744	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000131	0.00742	CbGpPWpGaD
Levofloxacin—ABCB1—lymph node—head and neck cancer	0.000129	0.00479	CbGeAlD
Levofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000128	0.00727	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000128	0.00725	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TYMS—head and neck cancer	0.000126	0.00712	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000124	0.00701	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CCNA1—head and neck cancer	0.000117	0.00665	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000101	0.00571	CbGpPWpGaD
Levofloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000101	0.00571	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000101	0.00571	CbGpPWpGaD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	9.51e-05	0.00539	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	9.51e-05	0.00539	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—RAD51—head and neck cancer	9.43e-05	0.00535	CbGpPWpGaD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	9.41e-05	0.00534	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	8.94e-05	0.00507	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—head and neck cancer	8.69e-05	0.00493	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	8.14e-05	0.00461	CbGpPWpGaD
Levofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.14e-05	0.00461	CbGpPWpGaD
Levofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.03e-05	0.00455	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.93e-05	0.00449	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	7.88e-05	0.00447	CbGpPWpGaD
Levofloxacin—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	7.77e-05	0.0044	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.67e-05	0.00435	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—NAT2—head and neck cancer	7.48e-05	0.00424	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	7.38e-05	0.00418	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	7.29e-05	0.00413	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	7.17e-05	0.00407	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—UROD—head and neck cancer	7.07e-05	0.00401	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.6e-05	0.00374	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.59e-05	0.00373	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	6.36e-05	0.0036	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—head and neck cancer	6.33e-05	0.00359	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	6.32e-05	0.00358	CbGpPWpGaD
Levofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	6.28e-05	0.00356	CbGpPWpGaD
Levofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	6.2e-05	0.00351	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—PTEN—head and neck cancer	6.1e-05	0.00346	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	5.98e-05	0.00339	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—CASP8—head and neck cancer	5.97e-05	0.00338	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—NAT2—head and neck cancer	5.78e-05	0.00327	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.74e-05	0.00326	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	5.7e-05	0.00323	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TYMS—head and neck cancer	5.66e-05	0.00321	CbGpPWpGaD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	5.6e-05	0.00317	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	5.55e-05	0.00315	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.43e-05	0.00308	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.17e-05	0.00293	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.17e-05	0.00293	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.09e-05	0.00289	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	4.71e-05	0.00267	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL2—head and neck cancer	4.51e-05	0.00256	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.48e-05	0.00254	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	4.42e-05	0.00251	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.34e-05	0.00246	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	4.33e-05	0.00246	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	4.31e-05	0.00244	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	4.24e-05	0.00241	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	4.24e-05	0.00241	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	4.24e-05	0.00241	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—head and neck cancer	4.16e-05	0.00236	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—UROD—head and neck cancer	3.86e-05	0.00219	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	3.83e-05	0.00217	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	3.7e-05	0.0021	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.66e-05	0.00208	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	3.65e-05	0.00207	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	3.5e-05	0.00199	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	3.46e-05	0.00196	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	3.41e-05	0.00193	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—head and neck cancer	3.19e-05	0.00181	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—UROD—head and neck cancer	3.08e-05	0.00175	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	3e-05	0.0017	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.94e-05	0.00167	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NAT2—head and neck cancer	2.93e-05	0.00166	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.85e-05	0.00162	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CCND1—head and neck cancer	2.85e-05	0.00162	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.82e-05	0.0016	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2.81e-05	0.0016	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.7e-05	0.00153	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	2.67e-05	0.00151	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.63e-05	0.00149	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—DPYD—head and neck cancer	2.57e-05	0.00146	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.53e-05	0.00143	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.5e-05	0.00142	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—YAP1—head and neck cancer	2.44e-05	0.00138	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	2.41e-05	0.00137	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.4e-05	0.00136	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.39e-05	0.00136	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—UROD—head and neck cancer	2.38e-05	0.00135	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MAPK3—head and neck cancer	2.35e-05	0.00133	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—MAPK1—head and neck cancer	2.3e-05	0.0013	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MAPK1—head and neck cancer	2.24e-05	0.00127	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.17e-05	0.00123	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.09e-05	0.00119	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.89e-05	0.00107	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—head and neck cancer	1.88e-05	0.00106	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—HRAS—head and neck cancer	1.85e-05	0.00105	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.79e-05	0.00101	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.7e-05	0.000965	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.7e-05	0.000965	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NAT2—head and neck cancer	1.6e-05	0.000909	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.48e-05	0.000837	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TYMS—head and neck cancer	1.47e-05	0.000831	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTM1—head and neck cancer	1.45e-05	0.000822	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.43e-05	0.00081	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—DPYD—head and neck cancer	1.41e-05	0.000797	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GPX1—head and neck cancer	1.39e-05	0.000787	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP1A1—head and neck cancer	1.37e-05	0.000779	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.36e-05	0.000771	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.35e-05	0.000763	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—YAP1—head and neck cancer	1.33e-05	0.000756	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NAT2—head and neck cancer	1.28e-05	0.000726	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.21e-05	0.000684	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—DPYD—head and neck cancer	1.12e-05	0.000636	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—YAP1—head and neck cancer	1.06e-05	0.000604	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NAT2—head and neck cancer	9.88e-06	0.00056	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—DPYD—head and neck cancer	8.66e-06	0.000491	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—YAP1—head and neck cancer	8.22e-06	0.000466	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS2—head and neck cancer	8.17e-06	0.000463	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TYMS—head and neck cancer	8.01e-06	0.000454	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8e-06	0.000454	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTM1—head and neck cancer	7.92e-06	0.000449	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GPX1—head and neck cancer	7.58e-06	0.00043	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP1A1—head and neck cancer	7.51e-06	0.000426	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTEN—head and neck cancer	7.13e-06	0.000404	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.98e-06	0.000396	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TYMS—head and neck cancer	6.39e-06	0.000363	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTM1—head and neck cancer	6.32e-06	0.000358	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GPX1—head and neck cancer	6.05e-06	0.000343	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP1A1—head and neck cancer	5.99e-06	0.00034	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CA—head and neck cancer	5.03e-06	0.000285	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TYMS—head and neck cancer	4.94e-06	0.00028	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.92e-06	0.000279	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.88e-06	0.000277	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GPX1—head and neck cancer	4.67e-06	0.000265	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.62e-06	0.000262	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS2—head and neck cancer	4.46e-06	0.000253	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AKT1—head and neck cancer	4.11e-06	0.000233	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTEN—head and neck cancer	3.89e-06	0.000221	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS2—head and neck cancer	3.56e-06	0.000202	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTEN—head and neck cancer	3.11e-06	0.000176	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.75e-06	0.000156	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.75e-06	0.000156	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTEN—head and neck cancer	2.4e-06	0.000136	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AKT1—head and neck cancer	2.24e-06	0.000127	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CA—head and neck cancer	2.19e-06	0.000124	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AKT1—head and neck cancer	1.79e-06	0.000102	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.69e-06	9.59e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AKT1—head and neck cancer	1.38e-06	7.84e-05	CbGpPWpGaD
